Abstract:Objective: To analyze the efficacy of branches portal vein embolization (TBPVE) combined with transcatheter arterial chemoembolization (TACE) on liver neoplasms. Methods: From August 2016 to May 2017, there were 13 patients including 11 males and 2 females with primary hepatocellular carcinoma who underwent TBPVE+ TACE , among whom there were 11 cases with a history of HBV infection.Average age of the 13 patients was (60.8±6.2)years. The live function of all patients were Child-Pugh A classification.The CT or MRI images of each patient was reconstructed and the standard liver volume(SLV) before TBPVE+ TACE was (1 181.2±49.3)ml, estimated future liver remnant(FLR) was (326.1±72.1)ml and FLR/SLV was (27.6±6.0)%.The puncture site for TBPVE was determined by the three-dimensional reconstruction of portal vein.CT scan or MRI, AFP and liver function test were repeated after one and two weeks after TBPVE+ TACE.FLR and FLR/SLV were calculated respectively.Hepatectomy would be performed if the patients agreed.The postoperative complications were analyzed. Results: On the 7thday after TBPVE+ TACE, the FLR/SLV was(42.6±8.0)% and the FLR increasement was(56.0±24.6)%.The level of AFP decreased from(87.9±81.8)μg/L to (29.7±20.9)μg/L.On the 14thday after TBPVE+ TACE, the FLR/SLV was(45.8±6.2)% and the FLR increasement was(71.8±29.0)%.Four patients underwent surgery which including 2 right hepatectomies and 2 right trisegmentectomies in 2 weeks after TBPVE+ TACE.Nine patients were performed with targeting intratumoral lactic acidosis TACE (TILA-TACE). No severe complication occurred in all patients. Conclusions: TBPVE could induce a rapid growth of the liver remnant but still with the concern of inducing the growth of neoplasms at the same time.To combine TACE in TBPVE therapy not also can the growth of neoplasms be prevented but also inducing its shrinking.This method might be a new mode for the treatment of hepatocellular carcinoma.

Surgical Treatment for Primary Liver Cancer with Portal Vein Tumor Thrombus(13 Cases Report)

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Combined Three Intervened Treatment of TACE,PEI And PVC in Advanced Liver Cancer

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

Surgical Treatment on Hepatocellular Carcinoma(HCC) with Bile Duct Tumor Thrombi

Hepatocellular Carcinoma with Bile Duct Thrombi: Analysis of Surgical Treatment.

Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus

[Hepatic Resection with Removal of Tumor Thrombi for Hepatocellular Carcinoma with Tumor Thrombi in Portal Vein and Curative Analysis].

Efficacy of Different Treatment Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

[Comparison of the Results and Therapies for Hepatocellular Carcinoma with Tumor Thrombosis in Portal Vein].

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Hepatocellular Carcinoma Associated with Tumor Thrombosis in the Portal Vein: the Effects of Different Treatments.

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Diagnosis and Treatment of Primary Liver Cancer with Cancer Thrombus of the Bile Duct

Multimodality Treatment in Hepatocellular Carcinoma Patients with Tumor Thrombi in Portal Vein

Primary hepatocellular carcinoma associated with portal vein tumor thrombus: report of one case with survival over 5 years and review of literature

Surgical Treatments of Primary Liver Cancer Patients with Severe Cirrhosis: a Report of 78 Cases CHEN

Clinical Significance of Removal of Tumor Thrombi in the Main Portal Vein in Patients with Hepatocellular Carcinoma

[On free amino acids in green caffee].

Resection of the Primary Liver Cancer of the Hepatic Hilus.

Comparison of Different Chemotherapeutic Patterns and Drug-Administration Ways after Resection of Hepatocellular Carcinoma with Tumor Thrombi in Portal Vein